IFN-α mediates the up-regulation of HLA class I on melanoma cells without switching proteasome to immunoproteasome

International Immunology

Volumn 15, Issue 12, 2003, Pages 1415-1421

  Cangemi, Giuliana ^a   Morandi, Barbara ^b   D'Agostino, Antonella ^a   Peri, Cristiano ^a   Conte, Romana ^b   Damonte, Gianluca ^c   Ferlazzo, Guido ^a   Biassoni, Roberto ^a   Melioli, Giovanni ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

HLA; IFN; Peptide; Proteasome

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; LOW MOLECULAR WEIGHT PROTEIN 2; LOW MOLECULAR WEIGHT PROTEIN 7; MELAN A; MESSENGER RNA; MULTICATALYTIC ENDOPEPTIDASE COMPLEX LIKE 1; PROTEASOME; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME MODIFICATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION TERMINATION;

ANTIBODIES; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; CELL LINE, TUMOR; CYSTEINE ENDOPEPTIDASES; FLOW CYTOMETRY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; MELANOMA; MULTIENZYME COMPLEXES; NEOPLASM PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 0346147029     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxg140     Document Type: Article

References (20)

1. Hershko, A. and Ciechanover, A. 1992. The ubiquitin system for protein degradation, Annu. Rev. Biochem. 61:761.
2. Townsend, A., Bastin, J., Gould, K., Brownlee, G., Andrew, M., Coupar, B., Boyle, D., Chan, S. and Smith, G. 1988. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J. Exp. Med. 168:1211.
3. Grant, E. P., Michalek, M. T., Goldberg, A. L. and Rock, K. L. 1995. Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation. J. Immunol. 155:3750.
4. Groll, M., Ditzel, L., Lowe, J., Stock, D., Bochtler, M., Bartunik, H. D. and Huber, R. 1997. Structure of 20S proteasome from yeast at 2.4 A resolution. Nature 386:463.
5. Morel, S., Levy, F., Burlet-Schiltz, O., Brasseur, F., Probst-Kepper, M., Peitrequin, A. L., Monsarrat, B., Van Velthoven, R., Cerottini, J. C., Boon, T., Gairin, J. E. and Van den Eynde, B. J. 2000. Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells. Immunity 12:107.
6. Macagno, A., Gilliet, M., Sallusto, F., Lanzavecchia, A., Nestle, F. O. and Groettrup, M. 1999. Dendritic cells upregulate immunoproteasomes and the proteasome regulator PA28 during maturation. Eur. J. Immunol. 29:4037.
7. Griffin, T. A., Nandi, D., Cruz, M., Fehling, H. J., Kaer, L. V., Monaco, J. J. and Colbert, R. A. 1998. Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. J. Exp. Med. 187:97.
8. Hallermalm, K., Seki, K., Wei, C., Castelli, C., Rivoltini, L., Kiessling, R. and Levitskaya, J. 2001. Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface. Blood 98:1108.
9. Toes, R. E., Nussbaum, A. K., Degermann, S., Schirle, M., Emmerich, N. P., Kraft, M., Laplace, C., Zwinderman, A., Dick, T. P., Muller, J., Schonfisch, B., Schmid, C., Fehling, H. J., Stevanovic, S., Rammensee, H. G. and Schild, H. 2001. Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J. Exp. Med. 194:1.
10. Kirkwood, J. M. 1998. Adjuvant IFN alpha2 therapy of melanoma. Lancet 351:1901.
11. Imai, K., Ng, A. K., Glassy, M. C. and Ferrone, S. 1981. Differential effect of interferon on the expression of tumor-associated antigens and histocompatibility antigens on human melanoma cells: relationship to susceptibility to immune lysis mediated by monoclonal antibodies. J. Immunol. 127:505.
12. Semino, C., Ferlazzo, G., Pietra. G., Pasquetti, W., Repetto, L., Rosso, R., Mariani, M. and Melioli, G. 1993. Heterogeneity of the alpha-interferon-mediated overexpression of class-I and class-II major histocompatibility complex molecules in primary cultured cancer cells. J. Biol. Regul. Homeost. Agents 7:99.
13. Cangemi, G., Millo, E., Damonte, G., Semino, C., Pietra, G., Benatti, U. and Melioli, G. 2000. Alpha-Interferon treatment induces quantitative modifications of HLA class I-associated peptides eluted from cultured cancer cell lines. Tissue Antigens 55:212.
14. Ferlazzo, G., Semino, C., Quartarone, G., Pietra, G. and Melioli, G. 1997. Adherent neoplastic cells grown at confluence downregulate HLA class I expression and enhance their susceptibility to lysis mediated by natural killer cells. Tissue Antigens 50:459.
15. Salter, R. and Cresswell, P. 1986. Impaired assembly and transport and transport of HLA A and B antigens in a mutant T × B hybrid. EMBO J. 5:943.
16. Storkus, W. J., Zeh, H. J., III, Salter, R. D. and Lotze, M. T. 1993. Identification of T-cell epitopes: apid isolation of class I-presented peptides from viable cells by mild acid elution. J. Immunother. 14:94.
17. De, M., Jayarapu, K., Elenich, L., Monaco, J. J., Colbert, R. A. and Griffin, T. A. 2003. β2 subunit propeptides influence cooperative proteasome assembly. J. Biol. Chem. 278:6153.
18. Wang, C., Pflugheber, J., Sumpter, R., Jr, Sodora, D. L., Hui, D., Sen, G. C. and Gale, M., Jr. 2003. Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication. J. Virol, 77:3898.
19. Chacko, M. S., Ma, X. and Adamo, M. L. 2002. Double-stranded ribonucleic acid decreases c6 rat glioma proliferation in part by activating protein kinase R and decreasing insulin-like growth factor I levels. Endocrinology 143:2144.
20. Kiefer, F., Vogel, W. F. and Arnold, R. 2002. Signal transduction and co-stimulatory pathways. Transplant. Immunol. 9:69.